A Phase I Study of Tagraxofusp With or Without Chemotherapy in Pediatric Patients with Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Is this Study for You?

Let's Get Started!

Details
Age

Child to Adult

Locations

Childrens Hospital Colorado

Principal Investigator
Photograph of Kelly Faulk

Kelly Faulk

Study ID

Protocol Number: 22-2360

More information available at ClinicalTrials.gov: NCT05476770

Categories

Is this Study for You?

Let's Get Started!

Not finding the right Study for you? Join ResearchMatch, a nation-wide registry connecting volunteers and researchers